Overview
GCP Auditing Training provides the practical skills needed to plan, conduct, report, and follow up on clinical trial audits. This training is essential for quality assurance professionals, clinical research associates, and regulatory affairs specialists who are responsible for ensuring GCP compliance. Whether you are new to auditing or seeking to enhance your skills, practical training is the key to building competence and confidence in the audit process.
Why Practical GCP Auditing Training Matters
GCP Auditing Training is essential for developing the skills needed to conduct effective audits. A well-trained auditor can:
- Plan and manage audit programmes effectively
- Conduct audits from initiation to follow-up
- Use remote auditing methods including virtual audits
- Evaluate auditor competence and maintain skills
- Apply the seven principles of auditing
- Identify and classify non-conformities with clear justification
Practical training ensures that auditors can apply their knowledge in real-world situations.
Detailed Course Breakdown
Course 1: GCP Global Auditor Certification Program
This training program defines the complete knowledge and performance requirements for personnel involved in clinical research to become certified global auditors for Good Clinical Practice (GCP).
Scope: The program integrates GCP requirements from ICH E6(R3), Health Canada Part C, Division 5, and FDA regulations with auditing practices based on ISO 19011:2026 for internal, second-party (vendor/CRO/site audits), and global regulatory compliance auditing.
Description of Modules: The curriculum covers:
- Regulatory Frameworks including ICH E6(R3), Health Canada Division 5, and FDA 21 CFR
- Auditing Practices based on ISO 19011:2026 including seven auditing principles
- Audit programme management including objectives, risks, resources, procedures, implementation, monitoring, review, and improvement
- Conducting an audit from initiation, preparation, execution, reporting, to follow-up
- Remote auditing methods including virtual audits, technology considerations, security, and contingency planning
- Competence and evaluation of auditors including personal behaviour, knowledge and skills, evaluation methods, and maintaining competence
Target Audience:
- Quality Assurance Personnel
- Clinical Research Associates (Monitors)
- Study Directors and Clinical Trial Managers
- Clinical Investigators and Site Staff
- Sponsor Personnel
- CRO Personnel
- IRB/IEC Members and Coordinators
- Audit Program Managers
Pricing: $499.00 with group discounts available.
FAQ:
- What practical skills will I learn in GCP auditing training? You will learn audit planning, execution, reporting, non-conformity identification, and CAPA management.
- What is the difference between internal and external auditing? Internal auditing is conducted by an organization’s own staff, while external auditing is conducted by independent third parties.
- What is remote auditing and how does it work? Remote auditing uses virtual methods and technology to conduct audits, particularly useful for global trials.
- How do you classify non-conformities? Non-conformities are classified as major, minor, or observation based on their impact on participant safety and data integrity.
- What is the importance of evidence-based approach in auditing? Auditors must rely on verifiable evidence to make their assessments.
Enroll Now: https://www.gxptrainings.com/courses/gcp-global-auditor-certification-program/
Course 2: Good Clinical Practices (ICH E6(R3) Focused)
This comprehensive training program provides an in-depth exploration of the ICH E6(R3) Good Clinical Practice guideline.
Scope: The curriculum is structured to guide participants through the entire guideline, covering the 11 fundamental principles, the expanded roles and responsibilities of sponsors and investigators, rigorous data governance frameworks, and the critical requirements for essential records.
Description of Modules: The curriculum covers:
- ICH E6(R3) overview and its significance in global clinical research
- 11 Fundamental Principles of GCP and their application
- Sponsor responsibilities including oversight and quality management
- Investigator responsibilities including delegation and supervision
- Informed consent requirements and documentation
- Data governance and integrity frameworks
- Essential records and Trial Master File requirements
- Safety reporting and pharmacovigilance obligations
- Risk-based approaches to trial management
- Digital technologies and decentralized trial elements
Target Audience:
- Clinical Investigators and Sub-Investigators
- Sponsor Personnel (Medical, Regulatory, Clinical Operations)
- Clinical Research Associates (Monitors)
- IRB/IEC Members and Coordinators
- Data Management and Biostatistics Professionals
- Quality Assurance and Compliance Staff
Pricing: $149.00 with group discounts available.
FAQ:
- How does ICH E6(R3) training support GCP auditing? It provides the regulatory knowledge needed to assess compliance.
- What are the 11 fundamental principles of GCP? They cover the ethical and scientific foundation of clinical trials.
- What is the Trial Master File? It is a collection of essential documents that demonstrate compliance with GCP and regulatory requirements.
- How does ICH E6(R3) address risk-based approaches? It emphasizes proportionate and risk-based approaches to trial management.
- Why is data governance important in clinical research? It ensures the integrity, accuracy, and reliability of clinical trial data.
Enroll Now: https://www.gxptrainings.com/courses/ich-e6r3-good-clinical-practices-gcp/
Course 3: Health Canada Good Clinical Practice Training
This comprehensive training program provides clinical research professionals with the knowledge and practical skills required to conduct clinical trials in compliance with Health Canada Food and Drug Regulations (Part C, Division 5) and the ICH E6(R3) GCP guideline.
Scope: The curriculum is aligned with Health Canada’s adoption of ICH E6(R3) effective April 1, 2026.
Description of Modules: The curriculum covers:
- Health Canada regulatory requirements for clinical trials (Part C, Division 5)
- ICH E6(R3) GCP principles and Annex 1
- Sponsor, Qualified Investigator, and REB responsibilities
- Clinical trial application (CTA) and amendment processes
- Informed consent requirements and participant protection
- Safety reporting obligations (AEs, SAEs, SUSARs)
- Data governance and record-keeping requirements
- Quality management and risk-based monitoring
- Investigational product management and GMP compliance
Target Audience:
- Sponsors (commercial and non-commercial/academic)
- Qualified Investigators (QIs) and Principal Investigators
- Research Ethics Board (REB) members and administrators
- Clinical Research Coordinators and study site personnel
- Contract Research Organizations (CROs) and Service Providers
Pricing: Competitive pricing with group discounts available.
FAQ:
- What practical skills will I learn in Health Canada GCP training? You will learn CTA preparation, informed consent, safety reporting, data governance, and quality management.
- What is the role of the Qualified Investigator under Health Canada? The QI must be qualified by education, training, and experience, and must supervise the conduct of the clinical trial.
- What are the requirements for informed consent under Health Canada? Informed consent must be obtained from all participants before trial participation.
- What is the Clinical Trial Application (CTA) process in Canada? Sponsors must submit a CTA to Health Canada for authorization.
- What is ALCOA+ and why is it important? ALCOA+ is a set of principles for ensuring data integrity in clinical research.
Enroll Now: https://www.gxptrainings.com/courses/health-canada-good-clinical-practice-training/
Course 4: HIPAA Clinical Data Privacy, Security & Compliance Training
This training program provides organizations and individuals with a comprehensive understanding of the legal, regulatory, and operational requirements for protecting health information in clinical research and healthcare delivery settings.
Scope: The program covers the full spectrum of privacy, security, and compliance obligations under U.S. federal law and international good practice standards.
Description of Modules: The curriculum covers 10 comprehensive sections:
- HIPAA Overview and regulatory landscape
- HIPAA Privacy Rule requirements and PHI protections
- HIPAA Security Rule requirements and ePHI safeguards
- HIPAA Breach Notification Rule requirements
- GCP and clinical data integrity requirements
- Security controls for information systems and cloud environments
- Regulatory compliance frameworks including FDA, NIST, and ISO
- Incident management and breach response
- Risk assessment methodologies
- Roles and responsibilities of Sponsors, CROs, Investigators, and technology vendors
Target Audience:
- Covered Entities under HIPAA
- Business Associates and their subcontractors
- Clinical Research Professionals
- Security and Compliance Professionals
Pricing: $249.00 with group discounts available.
FAQ:
- How does HIPAA training support GCP auditing? Auditors must verify that clinical trials comply with data privacy and security requirements.
- What is Protected Health Information (PHI)? PHI is health information that identifies an individual.
- What is the difference between the HIPAA Privacy Rule and Security Rule? The Privacy Rule protects the privacy of PHI, while the Security Rule establishes standards for protecting ePHI.
- What is a breach under HIPAA? A breach is the unauthorized acquisition, access, use, or disclosure of PHI.
- What is the role of a Business Associate Agreement? It establishes the terms for PHI handling and protection between a covered entity and a business associate.
Enroll Now: https://www.gxptrainings.com/courses/hipaa-clinical-data-privacy-security-compliance-training/
Course 5: Certified Regulatory Affairs Professional (CRAP)
This comprehensive certification program provides regulatory professionals with end-to-end knowledge of the global pharmaceutical regulatory landscape.
Scope: The program covers the complete drug development lifecycle from discovery through post-approval lifecycle management, with specific focus on the regulatory requirements of the FDA, EMA, and PMDA.
Description of Modules: The curriculum covers:
- Global Regulatory Framework overview
- Investigational New Drug (IND) applications
- New Drug Applications (NDA) for innovative pharmaceuticals
- Abbreviated New Drug Applications (ANDA) for generics
- Biologics License Applications (BLA) for biological products
- Orphan Drug Designation for rare disease treatments
- Special Programs including Accelerated Approval and Breakthrough Therapy
- Post-approval lifecycle management
- Regulatory agency interactions and meeting management
- Global regulatory strategy development
Target Audience:
- Regulatory Affairs Professionals
- Pharmaceutical Development and Formulation Scientists
- Quality Assurance/Quality Control Professionals
- Clinical and Nonclinical Development Professionals
Pricing: $799.00 with group discounts available.
FAQ:
- How does regulatory affairs training support GCP auditing? Understanding regulatory requirements helps auditors assess compliance.
- What is the difference between an IND and an NDA? An IND authorizes clinical trials, while an NDA requests marketing approval.
- What is the eCTD format and why is it important? eCTD is the standard format for regulatory submissions.
- What is the purpose of an Orphan Drug Designation? It provides incentives for developing drugs for rare diseases.
- What is the role of ICH in global drug development? ICH harmonizes regulatory requirements across regions.
Enroll Now: https://www.gxptrainings.com/courses/certified-regulatory-affairs-professional/
Get Your Team Offer
For organizations looking to enroll multiple participants, we offer specialized team packages and volume discounts. Please reach out to our partnership team to discuss your specific needs and scores.
Contact Us: https://www.gxptrainings.com/contact-us/
Authors
